Sara Mijwel
Overview
Explore the profile of Sara Mijwel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anandavadivelan P, Mijwel S, Wiklander M, Kjoe P, Luijendijk M, Bergh J, et al.
Sci Rep
. 2024 Jul;
14(1):15333.
PMID: 38961182
The protocol predefined aim of this study is to assess sustained effects of the OptiTrain trial on several health outcomes, 5 years after the baseline assessment. The OptiTrain study was...
2.
Anandavadivelan P, Cardinale D, Blomhoff R, Sunde B, Lassen K, Kleive D, et al.
Trials
. 2024 Jun;
25(1):356.
PMID: 38835083
Background: Patients diagnosed with pancreatic, biliary tract, and liver cancer often suffer from a progressive loss of muscle mass. Given the considerable functional impairments in these patients, high musculoskeletal weight...
3.
Kotte M, Bolam K, Mijwel S, Altena R, Cormie P, Wengstrom Y
Trials
. 2023 Feb;
24(1):116.
PMID: 36800978
Background: Regular exercise has been shown to have beneficial health effects in cancer survivors, including improving quality of life and other important health outcomes. However, providing people with cancer with...
4.
Mader T, Chaillou T, Alves E, Jude B, Cheng A, Kenne E, et al.
J Cachexia Sarcopenia Muscle
. 2022 Feb;
13(2):1151-1163.
PMID: 35170227
Background: Patients with breast cancer exhibit muscle weakness, which is associated with increased mortality risk and reduced quality of life. Muscle weakness is experienced even in the absence of loss...
5.
Ansund J, Mijwel S, Bolam K, Altena R, Wengstrom Y, Rullman E, et al.
Cardiooncology
. 2021 Feb;
7(1):7.
PMID: 33588948
Background: Adjuvant systemic breast cancer treatment improves disease specific outcomes, but also presents with cardiac toxicity. In this post-hoc exploratory analysis of the OptiTrain trial, the effects of exercise on...
6.
Rundqvist H, Velica P, Barbieri L, Gameiro P, Bargiela D, Gojkovic M, et al.
Elife
. 2020 Oct;
9.
PMID: 33095157
Exercise has a wide range of systemic effects. In animal models, repeated exertion reduces malignant tumor progression, and clinically, exercise can improve outcome for cancer patients. The etiology of the...
7.
Hiensch A, Mijwel S, Bargiela D, Wengstrom Y, May A, Rundqvist H
Med Sci Sports Exerc
. 2020 Sep;
53(3):496-504.
PMID: 32910094
Purpose: The randomized controlled OptiTrain trial showed beneficial effects on fatigue after a 16-wk exercise intervention in patients with breast cancer undergoing adjuvant chemotherapy. We hypothesize that exercise alters systemic...
8.
Hiensch A, Bolam K, Mijwel S, May A, Wengstrom Y
Support Care Cancer
. 2020 Mar;
28(11):5371-5379.
PMID: 32140973
Purpose: This study examined the Sense of Coherence (SOC) of patients participating in the randomized controlled 'Optimal Training for Women with Breast Cancer' (OptiTrain) study and assessed how patient characteristics...
9.
Wiggenraad F, Bolam K, Mijwel S, van der Wall E, Wengstrom Y, Altena R
Integr Cancer Ther
. 2020 Feb;
19:1534735420905003.
PMID: 32090630
We evaluate longitudinal changes in symptom clusters and core burdensome symptoms in breast cancer patients who participated in the OptiTrain trial. 240 women were randomized to 16 weeks of supervised...
10.
Hiensch A, Bolam K, Mijwel S, Jeneson J, Huitema A, Kranenburg O, et al.
Acta Physiol (Oxf)
. 2019 Oct;
229(2):e13400.
PMID: 31600860
Aim: Loss of skeletal muscle mass is a common clinical finding in cancer patients. The purpose of this meta-analysis and systematic review was to quantify the effect of doxorubicin on...